SecBot SecBot
EFFECT ·Filed Jun 1, 2026

CODX

Co-Diagnostics, Inc.
BEARISH
Impact 7/10
Horizondays Processed4mo ago SEC9999999995-26-001817
IPO/offering going effective
Actionable Insight ▼ Bearish

The shelf is now live, so the company can sell shares at any time without further SEC review. Watch for a prospectus supplement or 8-K announcing a takedown — any offering of even a fraction of this shelf would be highly dilutive given the tiny market cap.

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
CODX ▼ -80.16% at T+60d
SHORT call ✓ call won +80.16% · α vs SPY +81.39% · entry $6.20 → $1.23
Entry = T+0 close
Jun 1, 2026
via day close
T+1d
+0.32%
call -0.32% · α -0.18%
$6.22
settled 5mo ago
T+5d
-9.19%
call +9.19% · α +6.44%
$5.63
settled 5mo ago
T+20d
-50.00%
call +50.00% · α +48.70%
$3.10
settled 4mo ago
T+60d
-80.16%
call +80.16% · α +81.39%
$1.23
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Co-Diagnostics' universal shelf registration (File No. 333-296312) became effective on May 29, 2026, allowing the company to sell up to $150M in securities. With a market cap of only $31M, this creates a massive potential dilution overhang that the company can act on at any time.

Key Facts

  • Shelf registration (S-3) declared effective on 2026-05-29
  • Company can offer up to $150M in common, preferred, debt, warrants, units, or rights
  • Market cap is ~$31M, so the shelf represents ~4.8x current equity value
  • No committed offerings yet, but the shelf provides maximum capital-raising flexibility

Financial Impact

Potential dilution of up to ~$150M, representing ~4.8x current market cap

dilutionshare countequity value

Risk Factors

  • Immediate dilution risk if the company executes an offering
  • Overhang may pressure the stock even without a takedown
  • Company may need to raise cash given its small market cap and lack of analyst bullishness

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
0% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001817
Document: 9999999995-26-001817-index.html9999999995-26-001817
Document: 9999999995-26-001817.txt9999999995-26-001817
15 reports for CODX
Performance horizon
63% Hit rate @ T+20 5 of 8 directional calls Went positive at some point 8 of 10 best @ T+60▲ +63.88%May 21, 2026
Filters
Rows
Reports for CODX — sortable, filterable
TypeNow
Oct 26, 2026
1d ago
DEF 14A
BEARISH ★ 6/10
$0.5473awaiting T+20—$0.4690 (+14.31%)
Oct 15, 2026
12d ago
8-K/A
BEARISH ★ 6/10
$0.7151awaiting T+20—$0.4690 (+34.41%)
Oct 13, 2026
14d ago
8-K
BEARISH ★ 7/10
$1.07awaiting T+20—$0.4690 (+55.96%)
Sep 16, 2026
5w ago
8-K
NEUTRAL ★ 2/10
$0.9408 $1.07▲ +13.20%▲ +10.02%$0.4690 (−50.15%)
Sep 16, 2026
5w ago
8-K
NEUTRAL ★ 4/10
$0.9408 $1.07▲ +13.20%▲ +10.02%$0.4690 (−50.15%)
Sep 4, 2026
7w ago
DEFA14A
NEUTRAL ★ 2/10
$1.16 $1.10▼ −5.17%▼ −5.77%$0.4690 (−59.57%)
Sep 2, 2026
8w ago
EFFECT
BEARISH ★ 7/10
$1.16 $1.07▲ +7.76%▲ +7.68%$0.4690 (+59.57%)
Jul 31, 2026
12w ago
8-K
BEARISH ★ 7/10
$1.44 $1.21▲ +15.97%▲ +18.96%$0.4690 (+67.43%)
Jul 27, 2026
13w ago
424B5
BEARISH ★ 7/10
$1.41 $1.23▲ +12.77%▲ +16.15%$0.4690 (+66.74%)
Jun 1, 2026
21w ago
EFFECT
BEARISH ★ 7/10
$6.20 $3.10▲ +50.00%▲ +48.70%$0.4690 (+92.44%)
Showing 10 of 15

US Market Status

Market Closed — Opens in 7h 32m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 1, 2026